Literature DB >> 23039170

Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complications in vivo: inhibition by an anti-SSL5 antibody and the glycan Bimosiamose.

P C J Armstrong, H Hu, J Rivera, S Rigby, Y-C Chen, B P Howden, E Gardiner, K Peter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23039170     DOI： 10.1111/jth.12022

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

2.  Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.

Authors:  Zechariah Franks; Robert A Campbell; Adriana Vieira de Abreu; Jeffrey T Holloway; James E Marvin; Bjoern F Kraemer; Guy A Zimmerman; Andrew S Weyrich; Matthew T Rondina
Journal:  Thromb Haemost       Date:  2013-01-24       Impact factor: 5.249

3.  Superantigens and SARS-CoV-2.

Authors:  Adam Hamdy; Anthony Leonardi
Journal:  Pathogens       Date:  2022-03-23

Review 4.  Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2013-09-24       Impact factor: 4.546

5.  The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function.

Authors:  Stephen W Tuffs; David B A James; Jovanka Bestebroer; Amy C Richards; Mariya I Goncheva; Marie O'Shea; Bryan A Wee; Keun Seok Seo; Patrick M Schlievert; Andreas Lengeling; Jos A van Strijp; Victor J Torres; J Ross Fitzgerald
Journal:  PLoS Pathog       Date:  2017-09-07       Impact factor: 6.823

6.  Molecular basis determining species specificity for TLR2 inhibition by staphylococcal superantigen-like protein 3 (SSL3).

Authors:  Kirsten J Koymans; Louris J Feitsma; Adinda Bisschop; Eric G Huizinga; Jos A G van Strijp; Carla J C de Haas; Alex J McCarthy
Journal:  Vet Res       Date:  2018-11-28       Impact factor: 3.683
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.